• Vanda Announces Positive Study Results for Hetlioz americanpharmaceuticalreview
    December 11, 2018
    Vanda announced Hetlioz (tasimelteon) improved sleep quality and increased sleep duration in patients with Smith-Magenis Syndrome (SMS) in a pivotal placebo controlled clinical study....
PharmaSources Customer Service